Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism
- PMID: 9459144
- PMCID: PMC2151273
- DOI: 10.1038/bjc.1998.7
Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism
Abstract
Many reports have documented apoptotic death in different cell types within hours of exposure to cytotoxic drugs; lower drug concentrations may cause cell cycle arrest at G2/M and subsequent death, which has been distinguished from 'classic' apoptosis. We have analysed etoposide-induced cell death in two lymphoblastoid T-cell lines, CCRF-CEM and MOLT-4, specifically in relation to DNA cleavage as indicated by pulse-field gel and conventional electrophoresis. High (5 microM) concentration etoposide causes 50-kb cleavage of DNA that occurs at the same time as apoptotic morphology and internucleosomal cleavage. At lower concentrations (0.5-0.05 microM), sequential change may be discerned with altered gene expression being similar to that at high dose, but preceding cell cycle arrest and 50-kb cleavage. These last changes, in turn, clearly precede internucleosomal fragmentation of DNA, vital dye staining and morphological evidence cell death. The pattern of higher order fragmentation constitutes a sensitive indicator of commitment to cell death in these cells. Morphological evidence of cell death is associated with internucleosomal fragmentation in one of the lines, but the pattern of 50-kb DNA cleavage provides the clearest evidence of commonality in death processes occurring at low and high drug concentration.
Similar articles
-
Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death.Clin Cancer Res. 2000 Sep;6(9):3756-65. Clin Cancer Res. 2000. PMID: 10999770
-
Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.Cancer Res. 1993 Sep 15;53(18):4287-96. Cancer Res. 1993. PMID: 8364925
-
Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.Mol Pharmacol. 2000 Feb;57(2):296-307. Mol Pharmacol. 2000. PMID: 10648639
-
Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.Cancer Res. 1997 Feb 15;57(4):686-95. Cancer Res. 1997. PMID: 9044846
-
Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines.Leukemia. 2002 Sep;16(9):1705-12. doi: 10.1038/sj.leu.2402621. Leukemia. 2002. PMID: 12200685
Cited by
-
Stereoisomeric mitomycins interstrand crosslinks differently impact gene expression in MCF-7 and K562 cancer cells.Chem Biol Interact. 2025 Aug 25;417:111564. doi: 10.1016/j.cbi.2025.111564. Epub 2025 May 16. Chem Biol Interact. 2025. PMID: 40383468
-
Measuring Drug Response with Single-Cell Growth Rate Quantification.Anal Chem. 2023 Dec 12;95(49):18114-18121. doi: 10.1021/acs.analchem.3c03434. Epub 2023 Nov 28. Anal Chem. 2023. PMID: 38016067 Free PMC article.
-
Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells.Mol Cell Biochem. 2006 Nov;292(1-2):99-105. doi: 10.1007/s11010-006-9222-7. Epub 2006 May 30. Mol Cell Biochem. 2006. PMID: 16733797
-
Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukemia.Int J Hematol. 2002 Jun;75(5):519-27. doi: 10.1007/BF02982117. Int J Hematol. 2002. PMID: 12095154 Clinical Trial.
-
Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair.Cancer Sci. 2016 Sep;107(9):1250-5. doi: 10.1111/cas.12998. Epub 2016 Sep 1. Cancer Sci. 2016. PMID: 27341700 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical